The 2023 Seasonal Flu Booster, COVID-19, and RSV Vaccines

As autumn approaches, the need to stay vigilant against respiratory illnesses like COVID-19, Influenza, and RSV (respiratory syncytial virus) remains critical. Fortunately, the U.S. Food and Drug Administration (FDA) and the CDC Advisory Committee on Immunization Practices (ACIP) have recently approved new vaccines to safeguard the U.S. population from these potentially deadly viral illnesses.

2023-09-15T16:12:59-05:00September 20, 2023|

Illinois Department of Public Health Announces COVID-19 Antivirals Available in the Coming Weeks

The Illinois Department of Public Health (IDPH) is announcing two new COVID-19 oral antivirals, Paxlovid (Pfizer) and Molnupiravir (Merck), will be available in Illinois later this month. The antivirals are for those with mild-to-moderate COVID-19 who are at high risk for becoming severely ill, including hospitalization or death.

2022-01-19T17:21:42-06:00January 18, 2022|

CDC Recommends Pfizer Booster at 5 Months, Additional Primary Dose for Certain Immunocompromised Children

Today, CDC is updating our recommendation for when many people can receive a booster shot, shortening the interval from 6 months to 5 months for people who received the Pfizer-BioNTech COVID-19 Vaccine. This means that people can now receive an mRNA booster shot 5 months after completing their Pfizer-BioNTech primary series. The booster interval recommendation for people who received the J&J vaccine (2 months) or the Moderna vaccine (6 months), has not changed.

2022-01-19T17:26:23-06:00January 4, 2022|
Go to Top